Filing Flows › Comparisons › BKYI vs CYAB
Bio Key International vs Cyabra: BKYI and CYAB compared
Bio Key International is the larger company: $1.9M of revenue in its latest quarter (Q2 2026) against $1.9M for Cyabra (Q2 2026). Cyabra is growing faster (+39% against +13% a year earlier). Bio Key International is more profitable, with an operating margin of -27.6% against -168.4%.
Where the money goes: BKYI and CYAB
Bio Key International (BKYI) · Q2 2026
Bio Key International, Q2 2026: revenue $1.9M (+13% year over year), operating margin -27.6%, net loss $577K, operating cash flow −$846K. The chart follows the revenue to costs, profit and cash.
Cyabra (CYAB) · Q2 2026
Cyabra, Q2 2026: revenue $1.9M (+39% year over year), operating margin -168.4%, net loss $3.4M, operating cash flow −$2.4M. The chart follows the revenue to costs, profit and cash.
| Bio Key International (BKYI) | Cyabra (CYAB) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $1.9M | $1.9M |
| Revenue growth, Y/Y | +13% | +39% |
| Operating margin | -27.6% | -168.4% |
| Net earnings | −$577K | −$3.4M |
| Net margin | -30.0% | -185.6% |
| Operating cash flow | −$846K | −$2.4M |
Where the revenue comes from
Bio Key International
- License: $1.2M (64%)
- Hardware: $460K (24%)
- Service: $231K (12%)
Questions
Which is bigger, Bio Key International or Cyabra?
Bio Key International is the larger company: $1.9M of revenue in its latest quarter (Q2 2026) against $1.9M for Cyabra (Q2 2026).
Is Bio Key International or Cyabra growing faster?
Cyabra is growing faster (+39% against +13% a year earlier).
Which is more profitable, Bio Key International or Cyabra?
Bio Key International is more profitable, with an operating margin of -27.6% against -168.4%.
More: Bio Key International earnings · how Bio Key International makes money · Cyabra earnings · how Cyabra makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.